Home
About Us
About Us

Beijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs.
News
R&D
R&D

Primarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases.
Investor Relations
Investor Relations

Guided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
Our Businesses
- NL-PHARM
- Hounland
Our Businesses

Owns Beijing Northland Biopharmaceutical Co., Ltd. and Beijing Huons Pharmaceutical Co., Ltd., which are engaged in bioengineering drugs and ophthalmic products, respectively.

Language

中文简体

English

Home

Company Announcement

Beijing Stock Exchange

2026-01

Interim Announcement NORTHLAND: Progress Announcement Regarding the Use of Certain Idle Funds for Entrusted Financial Management

View source file

2025-12

Interim Announcement NORTHLAND: Announcement Regarding the Subsidiary's Recognition as a High-Tech Enterprise

View source file

2025-12

Temporary Announcement NORTHLAND: Progress Announcement Regarding the Use of Part of Idle Own Funds for Entrusted Wealth Management

View source file

2025-12

Temporary Announcement NORTHLAND: Progress Announcement Regarding the Use of Part of Idle Own Funds for Entrusted Wealth Management

View source file

2025-12

Temporary Announcement NORTHLAND: Progress Announcement Regarding the Use of Part of Idle Own Funds for Entrusted Wealth Management

View source file

2025-11

Interim Announcement NORTHLAND: Announcement Regarding the Approval Notice for Clinical Trials of Hydroxy Methazoline Hydrochloride Eye Drops Obtained by Subsidiary

View source file

< 1 2 >

Investor Contact

Tel：

+86 010 82890893

Fax：

+86 010 82890892

Email：

lilihua@northland-bio.com

Address：

No. 5, Kaituo Road, Shangdi, Haidian District, Beijing, Building A406, Zhongguancun Biomedical Park

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Friendly Links: Baidu | NORTHLAND

Contact Information

Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing

Hotline: +86 010-82890893

Email: northland@northland-bio.com

Website: www.northland-bio.com

Complaints Reporting Hotline: +86 010-82890893-8031

Complaints Reporting Email: pv@northland-bio.com

ADR information: Click to Download

Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.

Web site

NL-BIO

Scientific Research on Lower Limb Ischemia

NL003

Myocardial Infarction Scientific Research

NL005

Business license